Phytocannabinoids                        (news – undated)


Tetrahydrocannabinol- an interview with Akshat Rathi                   (transcript – undated)


STUDIES ON THE PHARMACOLOGY AND ACUTE TOXICITY OF COMPOUNDS WITH MARIHUANA ACTIVITY                                                         (abst – 1946)  xt=marihuana&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT


Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish (1st page – 1964)                                       


Chemical basis of hashish activity.                   (abst – 1970)


Some actions of delta-1 tetrahydrocannabinol and cannabidiol at cholinergic junctions. (full – 1971)                            


Activity of Dgr8-and Dgr9-Tetrahydrocannabinol and Related Compounds in the Mouse (abst – 1971)



A metabolic interaction in vivo between cannabidiol and DELTA1-tetrahydrocannabinol (full – 1972)                        


The Report of the National Commission on Marihuana and Drug Abuse Acute Effects of Marihuana       (full – 1972)


Water-soluble derivatives of 1 -tetrahydrocannabinol.               (abst- 1972)


Effect of Biogenic Amines and Cannabinoids on Bacterial Chemotaxis               (full – 1973)


Effects of marihuana in laboratory animals and in man                 (full – 1974)


A pilot study of orally administered DELTA1-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus                                               (full – 1974)


Smoked marijuana and oral delta-9-THC on specific airway conductance in asthmatic subjects     (full – 1974)               


Acute effects of smoked marijuana and oral delta9-tetrahydrocannabinol on specific airway conductance in asthmatic subjects.                                                       (abst – 1974)


Intravenous delta9-Tetrahydrocannabinol: Effects of ventilatory control and cardiovascular dynamics.   (full – 1975)



Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol. (abst – 1975)                                  


Effects of smoked marijuana in experimentally induced asthma.               (abst – 1975)


The influence of delta9-tetrahydrocannabinol, cannabinol and cannabidiol on tissue oxygen consumption.                                                (abst – 1975)


Analgesic effect of delta-9-tetrahydrocannabinol.                (abst – 1975)


The analgesic properties of delta-9-tetrahydrocannabinol and codeine.              (abst – 1975)


Epileptiform seizures in domestic fowl. V. The anticonvulsant activity of delta9- tetrahydrocannabinol.  (abst – 1975)                               


Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled cats.        (abst – 1975)            


Absence of interaction between delta9-tetrahydrocannabinol (delta-THC) and cannabidiol (CBD) in aggression, muscle control and body temperature experiments in mice.

(abst – 1975)      


Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients.       (full – 1976)


Anticonvulsant activity of delta9-tetrahydrocannabinol compared with three other drugs. (abst – 1976)                            


Antibacterial activity of delta9-tetrahydrocannabinol and cannabidiol.               (abst – 1976) plus


In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas.           (abst  – 1977)                         


Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects. (abst – 1977)


Delta-9-Tetrahydrocannibinol as an Antiemetic in Cancer Patients Receiving High-Dose Methotrexate   (full – 1979)                 


The effect of cannabichromene on mean blood pressure, heart rate, and respiration rate responses to tetrahydrocannabinol in the anesthetized rat                                       (abst – 1979)


Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking                                                             (abst – 1980)


Marihuana as a therapeutic agent for muscle spasm or spasticity.                 (abst – 1980)


Sedative activity of cannabis in relation to its delta’-trans-tetrahydrocannabinol and cannabidiol content.            (full -1981)


Activity of cannabis in relation to its delta’-trans-tetrahydro-cannabinol content.

(full – 1981)    


The seed and the soil: effect of dosage, personality and starting state on the response to delta 9 tetrahydrocannabinol in man.                         (full – 1981)


The cardiovascular and autonomic effects of repeated administration of delta-9- tetrahydrocannabinol to rhesus monkeys.                                                                 (abst – 1981)


Comparison of effects of marihuana cigarettes of three different potencies             (full – 1982)


Ocular  Effects  of  Topical  Administration  of  {Delta}9-Tetrahydrocannabinol  in  Man (link to PDF – 1982)

http://archopht.ama- hid=1&FIRSTINDEX=2960&resourcetype=HWCIT


Multiple-Drop Study of Topically Applied 1% {Delta}9-Tetrahydrocannabinol in Human Eyes   (link to PDF – 1983)

http://archopht.ama-   1&FIRSTINDEX=2800&resourcetype=HWCIT


Neurobehavioral actions of cannabichromene and interactions with delta 9- tetrahydrocannabinol.           (abst – 1983)                             


Respiratory and cardiovascular depressant effects of nabilone, N-methyllevonantradol and delta 9-tetrahydrocannabinol in anesthetized cats.                                  (abst – 1983)  ext=marihuana&searchid=1&FIRSTINDEX=1920&resourcetype=HWCIT


Allergenic properties of naturally occurring cannabinoids.                (abst – 1983)


Acute Effects of Natural and Synthetic Cannabis Compounds on Prolactin Levels in Human Males.        (abst – 1984)                  


Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta 9- tetrahydrocannabinol or cannabichromene.                                                      (abst – 1984)


Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol.                                          (abst – 1984)


Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds (abst – 1984)                          


The quasi-morphine withdrawal syndrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol.  (abst – 1985)  plus


Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.                                                                (abst – 1985)


The effect of delta-9-THC on human spasticity.             (abst – 1986)



(abst – 1987)  1097.1987.tb04757.x/abstract;jsessionid=E27DFF97974EDECC7DCDFFD1EED18D17.d03t03


Oral vs. Inhaled Cannabinoids for Nausea/Vomiting from Cancer Chemotherapy (full – 1988)                          


The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation.                                                           (abst – 1989)


Marijuana Smoking: Factors That Influence the Bioavailability of Tetrahydrocannabinol (full – 1990)                          


A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol.            (abst – 1990)                


Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. (abst – 1990)


Chronic Exposure to Delta 9-tetrahydrocannabinol Fails to Irreversibly Alter Brain Cannabinoid Receptors.                                                     (abst – 1991)


Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism.                                                       (full – 1992)


Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.                                                         (full – 1993)


Effects of delta 9-THC on marijuana smoking, dose choice, and verbal report of drug liking.       (full – 1994)             


Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice. (abst – 1994) ltext=marihuana&searchid=1&FIRSTINDEX=1840&resourcetype=HWCIT


Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin (abst – 1995)  T=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=2320&resourcetype=HWCIT


Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.     (abst – 1995)                  


AM630, a competitive cannabinoid receptor antagonist.              (abst – 1995)


Cannabinoids enhance human B-cell growth at low nanomolar concentrations. (abst – 1995)                            


NTP Technical Report on the Toxicology and Carcinogenesis Studies of 1-Trans-Delta9- Tetrahyrdocannabinol (CAS No. 1972-08-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies)           (full – 1996)                   


The effect of orally and rectally administered delta-9-tetrahydrocannabinol on spasticity : a pilot study with 2 patients.                                              (abst – 1996)


Toxicity and Carcinogenicity of {Delta}9-Tetrahydrocannabinol in Fischer Rats and B6C3F1 Mice         (abst – 1996)



Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains.      (abst – 1996)


Immunochemical localization of tetrahydrocannabinol (THC) in cryofixed glandular trichomes of Cannabis (Cannabaceae)                                                      (full – 1997)


The perceived effects of smoked cannabis on patients with multiple sclerosis. (abst – 1997) 


Study: THC Not Cancer-Causing           (news – 1997)


Cannabidiol and (−)DELTA9-tetrahydrocannabinol are neuroprotective antioxidants (full – 1998)


Cerebellar activity and disturbed time sense after THC.           (abst – 1998)


Treatment of Tourette’s Syndrome With Delta-9-Tetrahydrocannabinol            (letter – 1999)


Cannabis and cannabinoids: pharmacology and rationale for clinical use                (abst – 1999)


Cannabis: Discrimination of “Internal Bliss”?              (abst – 1999)


Advantages of polypharmaceutical herbal cannabis compared to single ingredient, synthetic tetrahydrocannabinol                                                                 (full – 2000)


Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation.                                                   (full – 2000)


Cannabinoids might reduce spasticity in multiple sclerosis              (full – 2000)


Variations of D9-THC content in single plants of hemp varieties            (full – 2000)


GC-MS analysis of the total delta9-THC content of both drug- and fiber-type cannabis seeds.     (abst – 2000)            


Endogenous cannabinoids and appetite.                (abst – 2000)


Cannabinoids in clinical practice.              (abst – 2000)


Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.                                                   (full – 2001)


Tetrahydrocannabinol for treatment of chronic pain               (abst – 2001)


Neuroprotection by Delta 9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity                                                             (abst – 2001)  ulltext=cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=70&sortspec=relevance&resourcet  ype=HWCIT


Clinical investigation of delta-9-tetrahydrocannabinol (THC) as an alternative therapy for overactive bladders in spinal cord injury (SCI) patients.                                                   (abst – 2001)


Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease            (full – 2002)  a7d081bcc2771d


The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.                                                     (full – 2002)


Cannabinoids and multiple sclerosis.                 (abst – 2002)


Cannabinoids in the treatment of pain and spasticity in multiple sclerosis. (abst – 2002)  tplus


Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN                                                     (full – 2003)  cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT


The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy                                                         (full – 2003)  cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT


Inhibition of tumor angiogenesis by cannabinoids                 (full – 2003)  0795fjev1?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=cannabis&andorexactfulltext=and&sear chid=1&FIRSTINDEX=20&sortspec=relevance&resourcetype=HWCIT


Effects of THC on Behavioral Measures of Impulsivity in Humans             (full – 2003)


Cannabis and the brain.            (full – 2003)


Treatment of Tourette Syndrome with Delta-9-Tetrahydrocannabinol (Delta9-THC): No Influence on Neuropsychological Performance                                       (full – 2003)


Cannabinoids: Potential Anticancer Agents             (full – 2003)


Cannabis use for chronic non-cancer pain: results of a prospective survey.              (abst – 2003)


The treatment of spasticity with D9-THC) in patients with spinal cord injury (abst – 2003)


Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. (abst – 2003)                         


Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.                                                 (abst – 2003)


Cannabis can help MS sufferers              (news – 2003)  (may need registration)


Differential Effects of  THC or CBD-rich Cannabis Extracts on  Working Memory in Rats          (full – 2004)           


Cannabinoids: Defending the Epileptic Brain                (full – 2004)


Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies            (full – 2004)                


The good and the bad effects of (−) trans-delta-9-tetrahydrocannabinol (DELTA9-THC) on humans     (abst – 2004)

2&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlV  ersion=0&_userid=10&md5=99df29b0ce94c395c01f5aad8825d28b


Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss.                                                          (abst – 2004)


Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early- morning behavior in young adults.                                                           (abst – 2004)


[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients.

(abst – 2004)     


THC in marijuana may block the spread of forms of cancer causing herpes viruses (news – 2004)


Cannabis truly helps multiple sclerosis sufferers                 (news – 2004) (may need registration)


Marijuana-like compounds may aid array of debiliating conditions ranging from Parkinson’s to pain         (news – 2004)


Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice (full – 2005)                       


Synergistic Interactions between Cannabinoids and Environmental Stress in the Activation of the Central Amygdala                                                        (full – 2005)


Protective effects of DELTA9-tetrahydrocannabinol against N-methyl-D-aspartate-induced AF5 cell death      (full – 2005)


The effects of DELTA9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide                                                         (full – 2005)


Pharmacokinetics and metabolism of the plant cannabinoids, delta9- tetrahydrocannabinol, cannabidiol and cannabinol.                                                                                 (abst – 2005)


Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N- arachidonoyldopamine (NADA) in the rat isolated aorta. (abst – 2005)


Cannabis may help keep arteries clear                 (news – 2005)  (may need registration)


Medical marijuana: study shows that THC slows atherosclerosis               (news – 2005)


Science: THC slows development of atherosclerosis in animal study              (news – 2005)


Cannabis Spray for Bipolar             (news – 2005)


Chemicals in Cannabis may help mentally ill               (news – 2005)


THC effective in appetite and weight loss in severe lung disease (COPD)           (news – 2005)


New Synthetic Delta-9-THC Inhaler Offers Safe, Rapid Delivery , Phase I Study (news – 2005)                             


A tale of two cannabinoids:The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.         (full – 2006)


Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In- Cachexia-Study-Group  (full – 2006)


A Molecular Link between the Active Component of  Marijuana and Alzheimer’s Disease Pathology      (full – 2006)


{Delta}9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation                                                 (full – 2006)


DELTA9-Tetrahydrocannabinol-Induced Apoptosis in Jurkat Leukemia T Cells Is Regulated by Translocation of Bad to Mitochondria                                                       (full – 2006)


Further Characterization of the Time-Dependent Vascular Effects of DELTA9- Tetrahydrocannabinol  (full – 2006)                                        


Cannabinoids and the Endocannabinoid System             (full – 2006)


The Cannabinoid Cb1 Receptor Antagonist Rimonabant Attenuates the Hypotensive Effect of Smoked Marijuana in Male Smokers.                                                             (full – 2006)


Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia. (abst – 2006)


Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief                                                           (abst – 2006)


A pilot clinical study of Delta(9)-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.                                                      (abst – 2006)


Delta(9)-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity (abst – 2006)  l_protects_hippocampal_neurons_from_excitotoxicity


The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.         (abst – 2006)                


The treatment of spasticity with Delta(9)-tetrahydrocannabinol in persons with spinal cord injury.           (abst – 2006)


An Experimental Study of Catechol-O-Methyltransferase Val(158)Met Moderation of Delta-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition

(abst – 2006)  techol_O_Methyltransferase_Val_158_Met_Moderation_of_Delta_9_Tetrahydrocannabinol_Induced_Effe  cts_on_Psychosis_and_Cognition


Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions.        (abst – 2006)                   


Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma.                                                (abst – 2006)


THC and prochlorperazine effective in reducing vomiting in women following breast surgery      (news – 2006)


Marijuana’s Active Ingredient Shown to Inhibit Primary Marker of Alzheimer’s Disease (news – 2006)                             


THC inhibits primary marker of Alzheimer’s disease                (news – 2006)


Cannabis destroys cancer cells                     (news – 2006)


The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: DELTA9- tetrahydrocannabinol, cannabidiol and DELTA9-tetrahydrocannabivarin                                                      (full – 2007)   med.Pubmed_ResultsPanel.Pubmed_SingleItemSupl.Pubmed_DiscoveryDbLinks&ordinalpos=1


Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia                                                   (full – 2007)


Opioid Antagonism of Cannabinoid Effects: Differences between Marijuana Smokers and Nonmarijuana Smokers                                                            (full – 2007)


The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.                                              (full – 2007)


Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors.     (full – 2007)


CB2 receptors in the brain: role in central immune function                (full – 2007)


DELTA9-Tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors                                                             (full – 2007)


Low dose combination of morphine and DELTA9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors                                                                (full – 2007)


On the pharmacological properties of Delta9-tetrahydrocannabinol (THC). (abst – 2007)                            


The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.                                               (abst – 2007)



THC improves appetite and reverses weight loss in AIDS patients                 (abst – 2007)


Repeated Treatment with Cannabidiol but Not Delta9-tetrahydrocannabinol Has a Neuroprotective Effect Without the Development of Tolerance                                                                    (abst – 2007)


Synergy between Delta(9)-tetrahydrocannabinol and morphine in the arthritic rat (abst – 2007) rahydrocannabinol_and_morphine_in_the_arthritic_rat




The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. (abst – 2007)


Delta(9)-tetrahydrocannabinol (Delta(9)-THC) prevents cerebral infarction via hypothalamic-independent hypothermia.                                                           (abst – 2007)






Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances. (abst – 2007)                             


Medicinal chemistry endeavors around the phytocannabinoids.              (abst – 2007)


Effects of a Selective Cannabinoid Agonist and Antagonist on Body Temperature in Rats (abst – 2007) T=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=800&resourcetype=HWCIT


Pot’s Active Ingredient Halts Lung Cancer Growth, Study Says            (news – 2007)


Cannabis can reduce Allergic Skin Reactions, latest research shows (news – 2007)  shows/


The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: DELTA9- tetrahydrocannabinol, cannabidiol and DELTA9-tetrahydrocannabivarin                                                  (full – 2008)


DELTA9-Tetrahydrocannabinol Content of Commercially Available Hemp Products

(full – 2008)  


Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of DELTA9-tetrahydrocannabinol                                       (full – 2008)


Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells                                                                   (full – 2008) ext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT#content-block


Cannabinoids in the management of difficult to treat pain              (full – 2008)


Cannabinoid receptors in acute and chronic complications of atherosclerosis (full – 2008)                         


Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.   (full – 2008)  StructureActivity-Study


The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor.                                                                 (full – 2008)


Delta-9-tetrahydrocannabinol pharmacokinetics               (abst – 2008)


High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells. (abst – 2008)                          


Effect of intrapulmonary tetrahydrocannabinol administration in humans.             (abst – 2008)


Science: THC reduces reflux of acid from the stomach                (news – 2008)


CSI: fingerprinting and drug detection in one              (news – 2008)


Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice                                                      (full – 2009)


Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. (full – 2009)                        


Cannabinoids DELTA9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells        (full – 2009)


Hydroxylation and Further Oxidation of DELTA9-Tetrahydrocannabinol by Alkane-Degrading Bacteria          (full – 2009)       


Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation (full – 2009)                       


Cannabinoid Receptor 1 Binding Activity and Quantitative Analysis of Cannabis sativa

L. Smoke and Vapor           (full – 2009)


Evaluation of Prevalent Phytocannabinoids in the Acetic Acid Model of Visceral Nociception     (full – 2009)


Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey                                                          (full – 2009)


Actions of delta-9-tetrahydrocannabinol in cannabis             (full – 2009)


Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma       (full – 2009)                        


TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action.             (full – 2009)


Cannabinoid action induces autophagymediated cell death through stimulation of ER stress in human glioma cells.                                                              (abst – 2009)


Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)- tetrahydrocannabinol in rats.                                                     (abst – 2009)


Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.        (abst – 2009)   bmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum


Modulation of effective connectivity during emotional processing by Delta9- tetrahydrocannabinol and cannabidiol.                                                                            (abst – 2009)   med_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum


Opposite Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology.                                   (abst – 2009)



Active cannabis chemicals halt prostate cancer cell growth                  (news – 2009)  growth.aspx


Marijuana Chemicals Ease MS Symptoms, Review Confirms                (news – 2009)


THC initiates brain cancer cells to destroy themselves                 (news – 2009)


Active Component Of Marijuana Has Anti-Cancer Effects, Study Suggests (news – 2009)                             


Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition (full – 2010)                       


Antitumorigenic Effects of Cannabinoids beyond Apoptosis             (full – 2010)


Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis                                                                (full – 2010)


Therapeutical use of the cannabinoids in psychiatry               (full – 2010)  44462010000500009&lng=en&nrm=iso&tlng=en


Effect of (-)-Delta(9)-tetrahydrocannabinoid on the hepatic redox state of mice. (full – 2010)  879X2010007500015&lng=en&nrm=iso&tlng=en


The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.                                                          (full – 2010)


Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full – 2010)                       


Antidepressant-like effect of Delta(9)-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.                                                                (full – 2010)


Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus       (full – 2010)              


Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells              (full – 2010)


Disposition of Cannabichromene, Cannabidiol, and DELTA9-Tetrahydrocannabinol and its Metabolites in Mouse Brain following Marijuana Inhalation Determined by High- Performance Liquid Chromatography-Tandem Mass Spectrometry                                                                                                     (full – 2010)


International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2                                                             (full – 2010)


Modulation of Adipocyte Biology by DELTA9-Tetrahydrocannabinol               (full – 2010)


Anti-tumoural effects of cannabinoid combinations  – Patent  TW201002315  (A) ― 2010-01-16            (full – 2010)  D&ND=3&date=20100116&DB=EPODOC&locale=en_EP


Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting                                                                      (link to PDF – 2010)


Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.                                       (abst – 2010)       cannabinol_is



Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.           (abst – 2010)                                           


The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti- invasion activity at low concentration and apoptosis induction at high concentration. (abst – 2010)                           


Chronic cannabinoid administration lowers viral replication in lymph nodes of SIV infected Rhesus macaques                                                           (abst – 2010)   RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=720&resourcetype=HWCIT


Exposure to a high-fat diet decreases sensitivity to DELTA9-tetrahydrocannabinol-induced motor effects in female rats                                                          (abst – 2010)


Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study.                                                        (abst – 2010)


THC Prevents MDMA Neurotoxicity in Mice.             (abst – 2010)


Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform- selective and potent inhibitors of human CYP1 enzymes.                                                   (abst – 2010)


Opposite Effects of DELTA-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology                                                                  (abst – 2010)


A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.                                                                (abst – 2010)  acute_and_chronic_Delta9_tetrahydrocannabinol_and_cannabidiol_in_C57BL/6JArc_mice_


Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study.                                                         (abst – 2010)


Oral Delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report.                                            (abst – 2010)


Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by DELTA9-tetrahydrocannabinol                                                                                 (abst – 2010)


Regulation of nausea and vomiting by cannabinoids                (abst – 2010)  5381.2010.01176.x/abstract;jsessionid=56CED9CE51B025C161AA2E821BEC94ED.d01t01


Tocolytic Effect of DELTA9-Tetrahydrocannabinol in Mice Model of Lipopolysaccharide— Induced Preterm Delivery: Role of Nitric Oxide                                                           (abst – 2010)


Key ingredient staves off marijuana memory loss                  (news – 2010)


Marijuana May Extend Life Expectancy Of Lou Gehrig’s Disease Patients, Study Says (news – 2010)                             


Science: Cannabidiol enhances the anti-cancer effects of THC on human brain cancer cells           (news – 2010)


Science: Cannabis effective in the treatment of TOURETTE Syndrome and attention deficit hyperactivity disorder (ADHD)                                                              (news – 2010)



A New Use for Medical Marijuana?                   (news – 2010)


Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: Evidence from an experimental murine model.                                                            (full – 2011)


Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa (full – 2011)


Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial

(full – 2011)     


Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.      (full – 2011)                


Prospects for cannabinoid therapies in basal ganglia disorders.              (full – 2011)


Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study.                                                                   (full – 2011)


US Patent Application 20110257256 – CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA                                       (full – 2011)


Influence of agroclimatic conditions on content of main cannabinoids in industrial hemp (Cannabis sativa L.)                                                 (full– 2011)


Cannabinoid Neuroimmune Modulation of SIV Disease.            (full – 2011)


Tolerance to chronic delta-9-tetrahydrocannabinol (DELTA⁹-THC) in rhesus macaques infected

with simian immunodeficiency virus.                  (abst – 2011)

tetrahydrocannabinol__%CE%94%E2%81%B9_THC  nodeficiency_virus_



Cannabidiol potentiates DELTA(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.

(abst – 2011)       


Combined effects of THC and caffeine on working memory in rats.               (abst – 2011)


Behavioral alterations in cystic fibrosis mice are prevented by cannabinoid treatment in infancy   (abst – 2011)  2/jbcpp.2011.005/jbcpp.2011.005.xml?rskey=wRYgJd&result=2&q=cannabinoid


DELTA(9)-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner                                                                     (abst – 2011)






The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys.      (abst – 2011) e_inhibitor_URB_597:_interactions_with_anandamide_in_rhesus_monkeys_


Effects of synthetic cannabinoids on electroencephalogram power spectra in rats. (abst – 2011)  ids_on_electroencephalogram_power_spectra_in_rats_


THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis.                                                     (abst – 2011)





Plasma cannabinoid pharmacokinetics following controlled oral delta9- tetrahydrocannabinol and oromucosal cannabis extract administration                                                                              (abst – 2011)  kinetics_following_controlled_oral_delta9_tetrahydrocannabinol_and_oromucosal_cannabis_extract_admi  nistration_


Pharmacokinetics of a combination of DELTA9-tetrahydro-cannabinol and celecoxib in a porcine model of hemorrhagic shock.                                                                 (abst – 2011)  ation_of_%CE%949_tetrahydro_cannabinol_and_celecoxib_in_a_porcine_model_of_hemor       rhagic_shock_


Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and DELTA(9) -tetrahydrocannabinol in BV-2 microglial cells                                   (abst – 2011)





Pre- and post-conditioning treatment with an ultra-low dose of DELTA9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage.

(abst – 2011)        


Heterogeneity in the composition of marijuana seized in California.                (abst – 2011)  ion_of_marijuana_seized_in_California_


Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.                                                   (abst – 2011) annabinoid_enriched_Cannabis_extracts_on_TRP_channels_and_endocannabinoid_metabolic_enzymes_


Sex Differences in Cannabinoid 1 vs. Cannabinoid 2 Receptor-Selective Antagonism of Antinociception Produced by DELTA9-Tetrahydrocannabinol and CP55,940 in the Rat

(abst – 2011)


Ingredient in cannabis restores taste for cancer patients                (news – 2011)


Marijuana Compound Treats Multiple Health Issues               (news – 2011)


Another Study Confirms Anti-Cancer Effects of THC and CBD               (news – 2011)  of-thc-and-cbd-1


Synaptic Targets of DELTA9-Tetrahydrocannabinol in the Central Nervous System. (full – 2012)


The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.        (full – 2012)


Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report. (full – 2012)                          


GPR18 in microglia: implications for the CNS and endocannabinoid system signaling (full – 2012)                         


Towards the use of non-psychoactive cannabinoids for prostate cancer.               (full – 2012)


So what do we call GPR18 now?               (full – 2012)


DELTA9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells                                                           (full – 2012)


NANOENCAPSULATED DELTA-9-TETRAHYDROCANNABINOL   – Patent US2012052119  (A1) ― 2012-03-01                                                                     (full – 2012)   T=D&ND=3&date=20120301&DB=EPODOC&locale=en_EP


Review article: The endocannabinoid system in normal and pathological brain ageing (abst – 2012)                          


DELTA(9) -THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson’s disease.     (abst – 2012)                            


Effect of delta-9-tetrahydrocannabinol on behavioral despair and on presynaptic and postsynaptic serotonergic transmission.                                                            (abst – 2012)


Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects.                                                         (abst – 2012)


Rimonabant eliminates responsiveness to workload changes in a time-constrained food- reinforced progressive ratio procedure in rats.                                                               (abst – 2012)


A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation.     (abst – 2012)                   


Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors. (abst – 2012)                           


Cannabinoid Receptor Activity In The Tumour Necrosis Factor (tnf)−α-Induced Increased Contractility Of The Guinea-Pig Isolated Trachea                                                                   (abst – 2012)   FORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCI   T


Effects of cannabinoids DELTA(9)-tetrahydrocannabinol, DELTA(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures.                                                       (abst – 2012)


Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.                                                        (abst – 2012)


Sex Differences in Cannabinoid 1 vs. Cannabinoid 2 Receptor-Selective Antagonism of Antinociception Produced by DELTA9-Tetrahydrocannabinol and CP55,940 in the Rat

(abst – 2012)


Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial.               (abst – 2012)


A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.                                                                                                (abst – 2012)


Effect of ion pairing on in vitro transcorneal permeability of a DELTA(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy.                                                   (abst – 2012)


Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis.                                                          (abst – 2012)


Cannabinoid facilitation of fear extinction memory recall in humans.              (abst – 2012)


Manipulating brain connectivity with Delta(9)-tetrahydrocannabinol: A pharmacological resting state FMRI study.                                                       (abst – 2012)


Brain regional differences in CB1 receptor adaptation and regulation of transcription. (abst – 2012)                          


Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations.                                                   (abst – 2012)


Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.                                              (abst – 2012)


Diuretic effects of cannabinoids.  (abst – 2012)


The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids.                                                     (abst – 2012)


DELTA9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice.                 (abst – 2012)


△9-Tetrahydrocannabinol Impairs the Inflammatory Response to Influenza Infection:

Role of Antigen Presenting Cells and the Cannabinoid Receptors 1 and 2.            (abst – 2012)


Acute effects of THC on time perception in frequent and infrequent cannabis users (abst – 2012)                             


Treatment of Tourette syndrome with cannabinoids.               (abst – 2012)


Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120.  (abst – 2012)                 


What place for cannabis extract in MS?            (abst – 2012)


Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR.                                            (abst – 2012)


Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats                                                        (abst – 2012)


Researchers study neuroprotective properties in cannabis              (news – 2012)


Simple Method: Isolating & Extracting INDIVIDUAL Cannabinoids… from BadKittySmiles     (forum post – 2012)  cannabinoids-badkittysmiles.html


Dissociation of the Pharmacological Effects of THC by mTOR Blockade.            (full – 2013)


Towards the use of non-psychoactive cannabinoids for prostate cancer               (full – 2013)


Amygdala activity contributes to the dissociative effect of cannabis on pain perception. (abst – 2013)                         


Differential Expression of Intracellular and Extracellular CB(2) Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes.                                                                (abst – 2013)


Surinabant, a selective CB(1) antagonist, inhibits THC-induced central nervous system and heart rate effects in humans.                                                       (abst – 2013)


Prior Exposure to THC Increases the Addictive Effects of Nicotine in Rats. (abst – 2013)                         


Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme.                                                  (abst – 2013)


DELTA9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2.                                                             (abst – 2013)


Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain.          (abst – 2013)                


A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany.                                                          (abst – 2013)


Cannabis and DELTA(9)-tetrahydrocannabinol (THC) for weight loss?                   (abst – 2013)


Science/Human: THC reduces sleep apnoea in small clinical study                     (news – 2013)  http://www.cannabis-

Share a link for